Thrive Wealth Management LLC Buys 144 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Thrive Wealth Management LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,649 shares of the healthcare conglomerate’s stock after acquiring an additional 144 shares during the period. Thrive Wealth Management LLC’s holdings in UnitedHealth Group were worth $793,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Apeiron RIA LLC raised its stake in shares of UnitedHealth Group by 0.8% during the 1st quarter. Apeiron RIA LLC now owns 2,581 shares of the healthcare conglomerate’s stock worth $1,222,000 after purchasing an additional 20 shares in the last quarter. Signet Financial Management LLC increased its holdings in shares of UnitedHealth Group by 2.2% during the 1st quarter. Signet Financial Management LLC now owns 964 shares of the healthcare conglomerate’s stock worth $491,000 after acquiring an additional 21 shares during the last quarter. Financial Partners Group Inc raised its position in shares of UnitedHealth Group by 4.3% in the fourth quarter. Financial Partners Group Inc now owns 509 shares of the healthcare conglomerate’s stock valued at $252,000 after purchasing an additional 21 shares during the period. Platform Technology Partners raised its holdings in UnitedHealth Group by 0.7% in the 1st quarter. Platform Technology Partners now owns 3,251 shares of the healthcare conglomerate’s stock valued at $1,536,000 after acquiring an additional 21 shares during the period. Finally, Carmichael Hill & Associates Inc. lifted its holdings in UnitedHealth Group by 11.4% during the 1st quarter. Carmichael Hill & Associates Inc. now owns 206 shares of the healthcare conglomerate’s stock worth $97,000 after purchasing an additional 21 shares during the last quarter. 85.69% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on UNH shares. Stephens reaffirmed an “overweight” rating and set a $560.00 target price on shares of UnitedHealth Group in a report on Friday, August 11th. JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $527.00 to $532.00 and gave the stock an “overweight” rating in a research note on Monday, July 17th. UBS Group lifted their price objective on shares of UnitedHealth Group from $510.00 to $520.00 and gave the company a “neutral” rating in a research note on Wednesday, July 19th. TD Cowen lowered their price target on UnitedHealth Group from $562.00 to $555.00 and set an “outperform” rating for the company in a report on Monday, July 17th. Finally, Truist Financial lowered their target price on UnitedHealth Group from $610.00 to $580.00 in a research note on Wednesday, June 14th. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $575.65.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $486.06 on Tuesday. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $558.10. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $450.24 billion, a P/E ratio of 21.75, a P/E/G ratio of 1.43 and a beta of 0.66. The company has a fifty day moving average of $492.05 and a 200-day moving average of $486.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share for the quarter, topping analysts’ consensus estimates of $5.92 by $0.22. UnitedHealth Group had a return on equity of 26.72% and a net margin of 6.06%. The business had revenue of $92.90 billion for the quarter, compared to the consensus estimate of $90.97 billion. During the same period in the prior year, the business earned $5.57 EPS. The firm’s revenue for the quarter was up 15.6% on a year-over-year basis. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 24.83 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Monday, September 11th will be paid a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. The ex-dividend date is Friday, September 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.65%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Andrew Witty sold 4,000 shares of the business’s stock in a transaction on Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total value of $2,024,760.00. Following the transaction, the chief executive officer now owns 78,573 shares of the company’s stock, valued at $39,772,866.87. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.35% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.